In-Silico Drug Discovery Market in North America Holds A
Companies covered in this study are Aragen Life Sciences Pvt. Ltd., Curia Global, Inc., Certara, USA., Charles River, Chemical Computing Group ULC.,...
Source: globenewswire.com
📰 Simcyp Simulator News
Simcyp Simulator News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Simcyp Simulator. Real-time updates on events, politics, business and more.
Certara introduces Simcyp Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development
21.11.2023 - Simcyp Biopharmaceutics helps drug developers replace costly clinical bioequivalence studies and optimize formulations for complex therapiesPRINCETON, N.J., Nov. 21, 2023 (GLOBE NEWSWIRE) - Certara, Inc. (Nasdaq: CERT), a global leader in ...
Ariane Lovell Sheila Rocchio Simcyp Biopharmaceutics Rob Aspbury Certara Scientific Software Simcyp Simulator
Source: wallstreet-online.de
RedHill Announces FDA sNDA Approval for Talicia
Israel - RedHill Biopharma Ltd. , a specialty biopharmaceutical company, announced the U.S. Food and Drug Administrations approval of its supplemental new drug application for Talicia[3],...
United States Colinw Howden June Almenoff World Health Organization Drug Administration University Of Tennessee College Medicine
Source: marketscreener.com
Certara Introduces New Simcyp™ Discovery Simulator for Early-Stage and Translational Drug Development
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Certara, Inc. (CERT) Q1 2022 Earnings Call Transcript
CERT earnings call for the period ending March 31, 2022.
United States United Kingdom David Deuchler Jacob Putman Barclays Vikram Kesavabhotla Dave Windley Jefferies
Source: fool.com
Certara, Inc. (CERT) Q4 2020 Earnings Call Transcript
Operator Ladies and gentlemen, thank you for standing by, and welcome to the Certara fourth-quarter 2020 earnings conference call. [Operator instructions] Please be advised that todays conference may be recorded. [Operator instructions] I would now like to hand the conference over to your speaker today, David Deuchler, investor relations. Please go ahead, sir. David Deuchler -- Investor Relations Good afternoon, everyone. Thank you for participating in todays conference call. On the call from ...
Source: fool.com